Endo International plc – (NASDAQ:ENDP) (TSE:ENL) saw a significant increase in short interest in January. As of January 31st, there was short interest totalling 22,990,959 shares, an increase of 6.3% from the January 12th total of 21,627,873 shares. Currently, 11.5% of the shares of the stock are sold short. Based on an average daily volume of 5,804,781 shares, the days-to-cover ratio is currently 4.0 days.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Flinton Capital Management LLC increased its holdings in Endo International by 64.4% in the second quarter. Flinton Capital Management LLC now owns 20,400 shares of the company’s stock valued at $228,000 after purchasing an additional 7,990 shares during the last quarter. UBS Asset Management Americas Inc. increased its holdings in Endo International by 4.4% in the fourth quarter. UBS Asset Management Americas Inc. now owns 221,992 shares of the company’s stock valued at $1,720,000 after purchasing an additional 9,438 shares during the last quarter. TIAA CREF Investment Management LLC increased its holdings in Endo International by 1.6% in the second quarter. TIAA CREF Investment Management LLC now owns 649,535 shares of the company’s stock valued at $7,255,000 after purchasing an additional 10,387 shares during the last quarter. Oakbrook Investments LLC bought a new stake in Endo International in the fourth quarter valued at about $133,000. Finally, LMR Partners LLP bought a new stake in Endo International in the third quarter valued at about $148,000. Institutional investors and hedge funds own 92.42% of the company’s stock.

Shares of Endo International (NASDAQ ENDP) opened at $6.32 on Wednesday. The firm has a market capitalization of $1,393.48, a price-to-earnings ratio of -0.28, a PEG ratio of 2.18 and a beta of 0.29. The company has a debt-to-equity ratio of 10.78, a quick ratio of 0.86 and a current ratio of 1.08. Endo International has a 52-week low of $5.77 and a 52-week high of $14.45.

ENDP has been the topic of a number of recent analyst reports. Guggenheim initiated coverage on Endo International in a research note on Tuesday, December 12th. They issued a “neutral” rating and a $8.50 price objective on the stock. Royal Bank of Canada reduced their price objective on Endo International from $9.00 to $8.00 and set a “sector perform” rating on the stock in a research note on Friday, November 10th. Cantor Fitzgerald reduced their price objective on Endo International from $9.00 to $7.00 and set a “neutral” rating on the stock in a research note on Friday, November 10th. BidaskClub raised Endo International from a “sell” rating to a “hold” rating in a research note on Tuesday, December 12th. Finally, Zacks Investment Research lowered Endo International from a “hold” rating to a “sell” rating in a research note on Monday, January 15th. Three analysts have rated the stock with a sell rating, thirteen have assigned a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. The stock has an average rating of “Hold” and an average target price of $10.54.

TRADEMARK VIOLATION NOTICE: “Endo International plc – (ENDP) Short Interest Up 6.3% in January” was first published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this news story on another website, it was stolen and reposted in violation of U.S. and international trademark and copyright law. The legal version of this news story can be read at https://theolympiareport.com/2018/02/14/endo-international-plc-endp-short-interest-up-6-3-in-january.html.

About Endo International

Endo International PLC, formerly Endo Health Solutions Inc is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel.

Receive News & Ratings for Endo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International and related companies with MarketBeat.com's FREE daily email newsletter.